Back to Search
Start Over
Fecal microbiota transplantation validates the importance of gut microbiota in an ApoE−/− mouse model of chronic apical periodontitis-induced atherosclerosis.
- Source :
- BMC Oral Health; 11/29/2024, Vol. 24 Issue 1, p1-13, 13p
- Publication Year :
- 2024
-
Abstract
- Background: Chronic apical periodontitis (CAP) has been linked to the development of atherosclerosis, although the underlying mechanisms remain unclear. This study aimed to investigate the role of gut microbiota disruption in CAP-induced atherosclerosis development, focusing on trimethylamine N-oxide (TMAO)-related metabolites. Methods: The study utilized fecal microbiota transplantation (FMT) to transfer gut microbiota from mice with CAP to healthy mice. Atherosclerosis development was assessed by analyzing lesions in the aortic arch and aortic root. Serum lipid and inflammatory factor levels were measured. Composition and diversity of gut microbiota were analyzed using targeted metabolomics, with a focus on the ratio of Firmicutes to Bacteroidetes. The expression of hepatic flavin-containing monooxygenase 3 (FMO3) and serum TMAO levels were also evaluated. Results: Mice receiving gut microbiota from CAP mice showed increased atherosclerotic lesions compared to controls, without significant differences in serum lipid or inflammatory factor levels. Alterations in gut microbiota composition were observed, characterized by an increase in the Firmicutes to Bacteroidetes ratio. Peptostreptococcaceae abundance positively correlated with atherosclerosis severity, while Odoribacteraceae showed a negative correlation. No significant differences were found in hepatic FMO3 expression or serum TMAO levels. Conclusions: The study confirms the role of gut microbiota disruption in CAP-mediated atherosclerosis development, independent of serum lipid or TMAO levels. Alterations in gut microbiota composition, particularly increased Firmicutes to Bacteroidetes ratio and specific bacterial families, were associated with atherosclerosis severity. These findings highlight the intricate interplay between gut microbiota and cardiovascular health in the context of CAP. [ABSTRACT FROM AUTHOR]
- Subjects :
- ATHEROSCLEROSIS risk factors
FECAL microbiota transplantation
RISK assessment
BIOLOGICAL models
INFLAMMATORY mediators
RESEARCH funding
GUT microbiome
PERIAPICAL diseases
LIPIDS
CHRONIC diseases
METABOLITES
MICE
GENE expression
ANIMAL experimentation
METABOLOMICS
PERIODONTITIS
BIOMARKERS
DISEASE complications
Subjects
Details
- Language :
- English
- ISSN :
- 14726831
- Volume :
- 24
- Issue :
- 1
- Database :
- Complementary Index
- Journal :
- BMC Oral Health
- Publication Type :
- Academic Journal
- Accession number :
- 181251220
- Full Text :
- https://doi.org/10.1186/s12903-024-05230-5